• About
  • Meet The Team
  • Privacy Policy
Sunday, February 28, 2021

Stocks Telegraph
  • Login
  • Home
  • Featured
  • Investing
  • Morning News
  • Mid Day Movers
No Result
View All Result
Stocks Telegraph
No Result
View All Result

TG Therapeutics (NASDAQ: TGTX) Ublituximab Receives Fast Track Designation In US

by Hasnain R
October 21, 2020
in Featured
Share on FacebookShare on Twitter

TG Therapeutics, Inc. (NASDAQ: TGTX) has announced Wednesday that it has received the Fast Track Designation for its ublituximab/umbralisib combo for the treatment of adult patients with chronic lymphocytic leukemia (CLL) from the FDA.

Fast Track is basically the program developed to speed up the review of drugs that treat serious diseases and address unmet medical needs. Filling an unmet medical need is to provide the treatment for those diseases for which no medical treatment is available earlier or offering a medical treatment that may be better than available therapy.

TG Therapeutics, Inc. (NASDAQ: TGTX) shares were trading up 0.31% at $28.75 at the time of writing on Wednesday. TG Therapeutics, Inc. share price went from a low point around $5.38 to briefly over $31.97 in the past 52 weeks, though shares have since pulled back to $28.75. TGTX market cap has remained high, hitting $334.37M at the time of writing.

The application of Fast Track designation is based on the data from UNITY-CLL Phase 3 study. The company has announced earlier in UNITY-CLL Phase 3 data that the treatment has shown a positive result. This Fast Track Designation is very important for the company. UNITY-CLL Phase 3 is the study to analyze the combination of ublituximab and umbralisib. Ublituximab is a glycoengineered anti-CD20 monoclonal antibody, and umbralisib is a dual inhibitor of PI3K-delta and CK1-epsilon.

Chronic lymphocytic leukemia (CLL) is a serious issue in the current period as more than 20,000 new cases have been reported alone in the US. After initial treatment, its symptoms disappear for a period of time but the disease is considered incurable. People need additional treatment after the return of the malignant cells.

Get The Best Stocks To Trade Every Day!

Join now to get the Stockstelegraph.com pre-market morning brief 100% free

Tags: Biotechnologychronic lymphocytic leukemiaCLLFast Track DesignationFDANASDAQ: TGTXTG Therapeutics IncTGTXTGTX stockUS

Related Posts

ASML Holding (NASDAQ: ASML) Announces 2020 Q3 Results
Featured

What dragged Vistra Corp (VST) about 25% lower?

February 27, 2021
High Flying Plasma Pharmaceuticals as FDA Approves Plasma-based COVID-19 Treatment
Featured

Three Top Coronavirus Stocks to Buy Anytime Soon

February 27, 2021
Tesla Inc. (NASDAQ: TSLA) Reportedly Discuss Nickel Supply Deal With Top Miner BHP
Featured

AMC Entertainment (AMC) Avoids Bankruptcy as Shares Pop Up

January 27, 2021
Top 3 Health Care Stocks that can attract investors in 2021
Featured

Top 3 Health Care Stocks that can attract investors in 2021

January 27, 2021
Sunworks (NASDAQ: SUNW) Stock Is Soaring Today. Here’s Why
Featured

Overstock.com (OSTK) Set to Convert its blockchain-based subsidiary to a limited partnership “Fund”

January 27, 2021
Top 15 Best Performing Medical Device Manufacture Companies Of 2020
Featured

3 Best Communication Stocks to Buy this year

January 26, 2021
Next Post
Why BIO-Key International (NASDAQ: BKYI) Stock Dropping Today?

Why BIO-Key International (NASDAQ: BKYI) Stock Dropping Today?

GameStop Corp. (GME) Stock has skyrocketed in the Pre-Market: What’s happening?

Top 3 Reasons Why AzurRx Biopharma Inc [AZRX] is Gaining Bullish Momentum
by ST Staff
February 25, 2021
0

GameStop Corp. (GME) shares have been on a skywalk. The videogame platform seller is captivating the attention in the market...

Read more

Early Morning Vibes: 4 Stocks We Like for Monday…

GEVO Inc [GEVO]  – A Top Stock To Watch For The Remainder Of 2020
by Hasnain R
February 22, 2021
0

The American stock markets could not be fired ahead last week. The results were limited and as you can see...

Read more

ReTo Eco-Solutions (RETO) Shares are Jumping High, What’s Happening?

Top Gainers as Positive Market Sentiment Grows
by Ali Hassan
February 23, 2021
0

The shares of ReTo are on a roll, probably on a bullish response from investors regarding some rumors. The shares...

Read more

The Three Best Hydrogen Stocks to Watch For in 2021

The Three Best Hydrogen Stocks to Watch For in 2021
by Ali Hassan
February 24, 2021
0

Hydrogen technology is the next big thing that is part of the Go Green movement. In the recent few months,...

Read more

Early Morning Vibes: 4 Top Trending Stocks To Watch Right Now

GEVO Inc [GEVO]  – A Top Stock To Watch For The Remainder Of 2020
by Hasnain R
February 23, 2021
0

US stock exchanges fell on Monday in line with the overall decline in risk sentiment in global markets, according to...

Read more
  • About
  • Meet The Team
  • Privacy Policy

© 2020 Stocks Telegraph - All Rights Reserved

No Result
View All Result
  • Home
  • Featured
  • Investing
  • Morning News
  • Mid Day Movers

© 2020 Stocks Telegraph - All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Get The Best Stocks To Trade Every Day!

Join now to get the Stockstelegraph.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.